hydroxychloroquine has been researched along with Adamantiades-Behcet Disease in 4 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 37-year-old female patient experienced oral ulcer and erythema nodosum on the right leg for over 12 months and resisted to Methylprednisolone and Thalidomide." | 4.12 | Refractory Behçet's disease treated with low-dose interleukin-2: A case report. ( He, J; Liu, T; Xiao, X; Zhou, W, 2022) |
| "Favipiravir was the most prescribed drug (74." | 1.72 | The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndrome. ( Atli, Z; Aydin, T; Balkan, II; Fresko, I; Hamuryudan, V; Hatemi, G; Melikoglu, M; Ozcifci, G; Ozguler, Y; Oztas, M; Seyahi, E; Tabak, F; Ugurlu, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozcifci, G | 1 |
| Aydin, T | 1 |
| Atli, Z | 1 |
| Balkan, II | 1 |
| Tabak, F | 1 |
| Oztas, M | 1 |
| Ozguler, Y | 1 |
| Ugurlu, S | 1 |
| Hatemi, G | 1 |
| Melikoglu, M | 1 |
| Fresko, I | 1 |
| Hamuryudan, V | 1 |
| Seyahi, E | 1 |
| Zhou, W | 1 |
| Liu, T | 1 |
| Xiao, X | 1 |
| He, J | 1 |
| Muruganandam, M | 1 |
| Rolle, NA | 1 |
| Sibbitt, WL | 1 |
| Cook, GB | 1 |
| Emil, NS | 1 |
| Fangtham, M | 1 |
| Reiter, KJ | 1 |
| Bankhurst, AD | 1 |
| Singer, NG | 1 |
| McCune, WJ | 1 |
1 review available for hydroxychloroquine and Adamantiades-Behcet Disease
| Article | Year |
|---|---|
Update on immunosuppressive therapy.
Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cycl | 1998 |
3 other studies available for hydroxychloroquine and Adamantiades-Behcet Disease
| Article | Year |
|---|---|
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndrome.
Topics: Adolescent; Adult; Amides; Antiviral Agents; Behcet Syndrome; Comorbidity; COVID-19; COVID-19 Drug T | 2022 |
Refractory Behçet's disease treated with low-dose interleukin-2: A case report.
Topics: Adult; Behcet Syndrome; Erythema Nodosum; Female; Humans; Hydroxychloroquine; Interleukin-2; Methylp | 2022 |
Characteristics of Behcet's Disease in the American Southwest.
Topics: Adult; Behcet Syndrome; Cross-Sectional Studies; Enzyme Inhibitors; Female; Humans; Hydroxychloroqui | 2019 |